ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 105 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $197,144 | -34.3% | 15,200 | -52.3% | 0.00% | -60.0% |
| Q4 2023 | $299,878 | -52.6% | 31,868 | -43.7% | 0.01% | -58.3% |
| Q3 2023 | $632,624 | -26.1% | 56,636 | +41.5% | 0.02% | -25.0% |
| Q2 2023 | $856,599 | +32.7% | 40,028 | +150.7% | 0.03% | +18.5% |
| Q1 2023 | $645,745 | +68.9% | 15,968 | +94.3% | 0.03% | +35.0% |
| Q4 2022 | $382,394 | -24.1% | 8,220 | -15.4% | 0.02% | 0.0% |
| Q3 2022 | $504,000 | -46.2% | 9,712 | -50.9% | 0.02% | -50.0% |
| Q2 2022 | $936,000 | +153.0% | 19,800 | +135.7% | 0.04% | +11.1% |
| Q2 2021 | $370,000 | +31.2% | 8,400 | +25.5% | 0.04% | -25.0% |
| Q4 2020 | $282,000 | – | 6,694 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
| Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
| ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
| Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
| Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
| Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
| AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
| Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |